CRS-HIPEC (cytoreductive surgery and hyperthermic intraperitoneal chemotherapy)
About Scott K.
I focus on surgical treatment of rare, aggressive, or metastatic cancers. For these conditions, treatment is highly personalized. I enjoy working closely with patients, their families, and a cross-disciplinary team of doctors to determine the best therapy for each individual, and to apply the latest research towards improving patients' lives. Facing any cancer diagnosis is difficult, and I strive to provide knowledge and guidance to help navigate these challenging times.
Scott K. Sherman
Training and Education
Complex General Surgical Oncology, American Board of Surgery
General Surgery, American Board of Surgery
American Association of Endocrine Surgeons
American College of Surgeons
Association for Academic Surgery
Central Surgical Association
Society of Surgical Oncology
MD, University of Chicago, Pritzker School of Medicine, Chicago
General Surgery, University of Iowa Hospitals & Clinics, Iowa City, Iowa
General Surgery Research, University of Iowa, Roy J. and Lucille A. Carver College of Medicine, Iowa City, Iowa
Complex General Surgical Oncology, University of Chicago, Chicago
4.82 out of 5 (147 ratings)
The number of stars is an average of all responses to provider-related questions from Press Ganey patient satisfaction surveys. Responses are measured on a scale of 1 to 5, with 5 being the best score. About our ratings.